ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence
{{output}}
Although angiotensin-converting enzyme inhibitors are frequently used as antihypertensive agents to lower blood pressure and slow progression of nephropathy in patients with type 2 diabetes, evidence of their efficacy has been drawn primarily from small trials... ...
